Arcutis Biotherapeutics stockARQT
Arcutis Biotherapeutics trades at $27.00, 22.4% below its 52-week high (Nov 4, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. −7.0% year to date, +10.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for ARQT — after you log in
Open the terminalFrequently asked questions about Arcutis Biotherapeutics
What is the Arcutis Biotherapeutics stock price?
At the close on Nov 5, 2026: $27.00 (−20.70% on the day). 52-week high: $34.80 on Nov 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Arcutis Biotherapeutics report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed 0% year over year, revenue +45%.
Does Arcutis Biotherapeutics pay dividends?
No, Arcutis Biotherapeutics does not pay dividends.
Where does Arcutis Biotherapeutics trade and how to buy it?
Ticker ARQT, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Arcutis Biotherapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ARQT are in the terminal after you log in.